Visão geral da empresa Julphar
12 escritóriosLocalizações
Julphar strives to provide a better quality of life for the entire family, by delivering best-in class solutions and real value with compassion and professionalism.
Julphar is one of the largest pharmaceutical manufacturers in the Middle East and Africa and one of the leading producers of insulin in the world.
The company was established in 1980 under the guidance of Sheikh Saqr Bin Mohammed Al Qasimi, the late ruler of Ras Al Khaimah, and since then Julphar has been delivering high quality, innovative and affordable healthcare solutions to families across the globe.
Our business is centred around General Medicines in the retail pharmacy channel and hospitals as well as speciality Products, Our medicines target major therapeutic segments including Diabetes, Gastrointestinal Tract (GIT), Respiratory, Pain Management, Wounds and Scars, Anti-infectives, Anemia, Gynecology, Dermatology, Erectile Dysfunction and Cardiology.
We employ around 3,400 people and distribute our products to more than 30 countries on five continents. Our 12 internationally accredited manufacturing facilities can produce up to one million boxes of medicine a day. In 2012, we became one of the world’s largest producers of insulin thanks to our state-of-the-art UAE-based biotechnology facility.
The company was established in 1980 under the guidance of Sheikh Saqr Bin Mohammed Al Qasimi, the late ruler of Ras Al Khaimah, and since then Julphar has been delivering high quality, innovative and affordable healthcare solutions to families across the globe.
Our business is centred around General Medicines in the retail pharmacy channel and hospitals as well as speciality Products, Our medicines target major therapeutic segments including Diabetes, Gastrointestinal Tract (GIT), Respiratory, Pain Management, Wounds and Scars, Anti-infectives, Anemia, Gynecology, Dermatology, Erectile Dysfunction and Cardiology.
We employ around 3,400 people and distribute our products to more than 30 countries on five continents. Our 12 internationally accredited manufacturing facilities can produce up to one million boxes of medicine a day. In 2012, we became one of the world’s largest producers of insulin thanks to our state-of-the-art UAE-based biotechnology facility.
